Company Overview
Takeda Development Centre Europe Ltd. is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Monday 21 September 1998, so this is a well established company. Takeda Development Centre Europe Ltd. has been in business for 27 years and 6 months. The accounts status is full and the accounts are next due on Wednesday 31 December 2025.
Registered Address

1 Kingdom Street, London, W2 6BD
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameTAKEDA DEVELOPMENT CENTRE EUROPE LTD.
Company Number03638034
Registered Office Address1 Kingdom Street
 W2 6BD
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date21/09/1998
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2026
Accounts Last Made Up Date31/03/2025
Accounts Account CategoryFULL
Returns Next Due Date19/10/2016
Returns Last Made Up Date21/09/2015
Previous Company NameChanged Date
TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTRE (EUROPE) LTD26 Jun 2013
TAKEDA EUROPE RESEARCH AND DEVELOPMENT CENTRE LTD15 Mar 2006
Directors & Members
Show Resigned
Seyda Memis - Director
(Turkish, 47 years old, born March 1979)
Appointed 31 August 2025
 Active
Itaru Miura - Director
(Japanese, 51 years old, born November 1975)
Appointed 04 November 2025
 Active
Marc Page - Director
(British, 41 years old, born February 1985)
Appointed 10 May 2021
 Active
Secretaries
Show Resigned
Bryan Driscoll - Secretary
(British)
Appointed 21 December 2006
 Active
Other Company Directorships
Seyda Memis
ADAPTATE BIOTHERAPEUTICS LTD
AURALIS LIMITED
BAXALTA UK INVESTMENTS LTD.
BAXALTA UK LIMITED
GAMMADELTA THERAPEUTICS LTD
SHIRE PHARMACEUTICAL CONTRACTS LIMITED
SHIRE PHARMACEUTICALS GROUP
SHIRE PHARMACEUTICALS LIMITED
TAKEDA UK LIMITED
Itaru Miura
No companies found
Marc Page
NPS PHARMA UK LIMITED
SHIRE BIOPHARMACEUTICALS HOLDINGS
SHIRE BIOTECH UK HOLDINGS LIMITED
SHIRE EUROPE FINANCE
SHIRE EUROPE LIMITED
SHIRE GLOBAL FINANCE
SHIRE HOLDINGS EUROPE LIMITED
SHIRE HOLDINGS UK LIMITED
SHIRE PHARMACEUTICAL CONTRACTS LIMITED
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
SHIRE PHARMACEUTICALS LIMITED
SHIRE PHARMACEUTICALS SERVICES LIMITED
TAKEDA CAMBRIDGE LIMITED
TAKEDA CORPORATE SERVICES LIMITED
VIROPHARMA LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2012 31-Mar-2011
Balance Sheet
Fixed Assets 2,604,731 2,604,731 2,903,254
Current Assets 31,086,189 31,086,189 41,584,571
Creditors Due Within One Year 28,711,116 28,711,116 39,824,401
Working Cap 2,375,073 2,375,073 1,760,170
Total Assets Less Current Liabilities 4,979,804 4,979,804 4,663,424
Long-term Liabilities 99,916 99,916 0
Net Assets 4,879,888 4,879,888 4,663,424
Share Capital & Reserves
Share Cap 800,000 800,000 800,000
Profit & Loss Reserves 4,079,888 4,079,888 3,863,424
Other Reserves 0 0 0
Shareholders Funds 4,879,888 4,879,888 4,663,424
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2012 31-Mar-2011
Tangible Fixed Assets - - -
Fixed Assets 7.7% 7.7% 6.5%
Stocks Inventory 0.0% 0.0% 0.0%
Debtors 86.0% 86.0% 70.9%
Cash Bank In Hand 6.3% 6.3% 22.6%
Current Assets 92.3% 92.3% 93.5%
Creditors Due Within One Year 85.2% 85.2% 89.5%
Net Current Assets Liabilities 7.0% 7.0% 4.0%
Creditors Due After One Year 0.0% 0.0% 0.0%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 14.5% 14.5% 10.5%
Called Up Share Capital 2.4% 2.4% 1.8%
Share Capital Allotted Called Up Paid 2.4% 2.4% 1.8%
Profit Loss Account Reserve 12.1% 12.1% 8.7%
Shareholder Funds 14.5% 14.5% 10.5%
Capital Employed - - -
Total Assets Less Current Liabilities 14.8% 14.8% 10.5%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2012 31-Mar-2011
Liquidity Ratio 1.1 1.1 1.0
Solvency Ratio 1.2 1.2 1.1
Reserves to Assets 0.1 0.1 0.1
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 2
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2012 31-Mar-2011
Assets 33,690,920 33,690,920 44,487,825
Debt 28,811,032 28,811,032 39,824,401
Net Assets/Debt 4,879,888 4,879,888 4,663,424

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet this level of net assets suggests total debts and obligations were moderately well covered.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet this level of net assets suggests total debts and obligations were moderately well covered.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The current section of the balance sheet has positive working capital. We would normally consider this positively. Total reserves including retained profitability and movement in reserves appeared positive. We would normally view a company positively for this. For the size of the company inferred by the balance sheet this level of net assets suggests total debts and obligations were moderately well covered.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around W2 6BD
RYBAR LABORATORIES LIMITED
1 Kingdom Street, London, W2 6BD
SYNLAB HOLDCO III LIMITED
4th Floor 1 Kingdom Street, London, W2 6BD
STRATISNET LIMITED
2 Kingdom Street, London, W2 6BD
GENON LABORATORIES LTD
1 More London Place, London, W2 6BD
VLSI HOLD LIMITED
Unit 1b Science Park Babbage Way, Clyst Honiton, Exeter, W2 6BD
CTDS 2015 LIMITED
1 More London Place, London, W2 6BD
TDDS 2015 LIMITED
1 More London Place, London, W2 6BD
PTDS LIMITED
1 More London Place, London, W2 6BD
MORISON GLOBAL EUROPE LIMITED
167-169 Great Portland Street, 5th Floor, London, W2 6BD
COGNIZANT BUSINESS SERVICES UK LIMITED
280 Bishopsgate, London, W2 6BD
Document Filings
Appointment of Itaru Miura as a director on 4 November 2025
Confirmation statement made on 21 September 2025 with no updates
Appointment of Seyda Atadan Memis as a director on 31 August 2025
Termination of appointment of Peter Michael Grubin as a director on 31 August 2025
Director's details changed for Mr Peter Michael Grubin on 29 May 2025
Confirmation statement made on 21 September 2024 with no updates
Satisfaction of charge 2 in full
Confirmation statement made on 21 September 2023 with no updates
Confirmation statement made on 21 September 2022 with no updates
Termination of appointment of Charmaine Linda Reid as a director on 31 August 2022
Appointment of Mr Peter Michael Grubin as a director on 30 August 2022
Confirmation statement made on 21 September 2021 with no updates
Termination of appointment of David Isaacs as a director on 30 June 2021
Appointment of Mr Marc Stuart Page as a director on 10 May 2021
Termination of appointment of Sian Cheyne as a director on 16 March 2021
Termination of appointment of James Edward Carlson as a director on 20 November 2020
Appointment of Mrs Charmaine Linda Reid as a director on 17 November 2020
Confirmation statement made on 21 September 2020 with no updates
Registered office address changed from 61 Aldwych London WC2B 4AE to 1 Kingdom Street London W2 6BD on 31 December 2019
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free